Weight loss drugs similar to Ozempic, such as Ozempic, Wegovy, and Mounjaro, belong to the group of GLP-1 agonists. New research suggests these drugs may help the heart recover after a heart attack. They promote the restoration of blood flow in small blood vessels that often remain blocked even after the main artery is reopened by doctors. These drugs thus protect the heart in addition to their effect on weight loss. Studies show that semaglutide reduces the risk of cardiovascular events by 20%, heart attack by 28%, and stroke by 7%.[1] Semaglutide treatment also improves heart failure symptoms and physical fitness in obese patients.[1]